A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months
This study investigated the safety of administration of long-acting parenteral testosterone undecanoate (TU) to 122 hypogonadal, mainly elderly men, aged 59.6 ± 8.0 years (range 18-83 years old), with baseline testosterone levels between 5.8 and 12.1 nmol l-1 (mean ± SD = 9.3 ± 1.7). Patients were f...
Saved in:
Main Authors: | Haider A., Gooren L.J.G., Padungtod P., Saad F. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-78649582389&partnerID=40&md5=cae7178624700c1cfcf6df1f621f28f5 http://cmuir.cmu.ac.th/handle/6653943832/7511 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months
by: A. Haider, et al.
Published: (2018) -
Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate
by: Haider A., et al.
Published: (2014) -
Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate
by: A. Haider, et al.
Published: (2018) -
Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein
by: Haider A., et al.
Published: (2017) -
Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein
by: Ahmad Haider, et al.
Published: (2018)